Technical Analysis - OREXIGEN THERAPEUTICS (Stock Symbol: OREX)
OREX Pivot Point Support and Resistance Levels
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
Select formula to calculate Traditional Pivot Point
OREX Pivot Points (traditional) calculated for the Next trading session
|Support / Resistance||Daily OREX|
|Used Period||10/24/2014||10/20/2014 - 10/24/2014||10/01/2014 - 10/24/2014|
|Used OREX Quotes||O:4.40;H:4.42;L:4.30;C:4.38||O:4.08;H:4.94;L:4.02;C:4.38||O:4.26;H:4.94;L:3.11;C:4.38|
Daily OREX support and resistance levels are based on the OREX quotes recorded on 10/24/2014
Open: 4.40; High: 4.42; Low: 4.30; Close: 4.38.
Weekly OREX support and resistance levels are based on the OREX quotes recorder in period from 10/20/2014 to 10/24/2014
Open: 4.08; High: 4.94; Low: 4.02; Close: 4.38.
Monthly OREX support and resistance levels are based on the OREX quotes recorded in period from 10/01/2014 to 10/24/2014
Open: 4.26; High: 4.94; Low: 3.11; Close: 4.38.
Daily OREX Pivot Points (traditional and non-traditional)
support and resistance levels are calculated for the Next trading session
|Pivot Point Level||Traditional|